Nasdaq Posts Four-Week Win Streak, Longest Since May; Equal-Weight S&P 500 Snaps Seven-Week Losing Streak
nashnova research
The Nasdaq posted a fourth straight weekly gain — its longest winning streak since May — while the equal-weight S&P 500 snapped a seven-week losing run, signaling the rally is broadening beyond a handful of mega-cap tech names.
Where did the three major indexes close on Friday?
The S&P 500 rose 46.18 points (+0.6%) to 7,811.54; the Dow gained 423.31 points (+0.8%) to 51,654.95; the Nasdaq added 172.83 points (+0.6%) to 27,366.17.
The Nasdaq notched its fourth consecutive weekly advance, the longest such streak since May.
All three indexes closed higher, capping a week of broad-based gains.
The equal-weight S&P 500 bounced — why does that matter?
The equal-weight S&P 500 — a version that gives every stock the same weight, so mega-caps can't dominate the reading — ended a seven-week losing streak.
Per FactSet, that slide was the longest weekly losing run since 2022.
This means → the prior rally had been heavily concentrated in a few large-cap tech names while most stocks were actually falling. This week's rebound shows money is spreading to more sectors, widening the market's foundation.
OpenAI revenue missed expectations — how did tech digest it?
The Financial Times reported that OpenAI's revenue came in below expectations, briefly rattling markets intraday.
Tech stocks still finished the session higher; the dip was absorbed without lasting damage.
In plain terms = the market digested the bad headline without panic selling, suggesting bullish sentiment in tech remains intact for now.
What's on the radar next week?
Major banks begin reporting quarterly earnings, officially kicking off third-quarter earnings season.
This is a validation window for whether tech can sustain its winning streak — hard numbers will show if corporate profits are keeping pace with stock prices.
This means → solid bank results could spread confidence further across sectors; a disappointment could put the current streak to the test.
市场有风险，内容仅供研究参考，不构成投资建议。